neostigmine has been researched along with Concussive Convulsion in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flodmark, S | 1 |
1 other study available for neostigmine and Concussive Convulsion
| Article | Year |
|---|---|
Clinical detection of blood-brain barrier alteration by means of EEG. I. EEG effects induced by two anticholinesterase agents--the lipid-soluble physostigmine and the lipid-insoluble neostigmine--on two different types of focal cerebral lesion in man.
Topics: Adult; Blood-Brain Barrier; Brain Injuries; Brain Neoplasms; Electroencephalography; Epilepsy, Post- | 1965 |